APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Drug and Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pet Drug and Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026196 pages

Choose your research edition.

Industry ResearchPet Drug and Vaccine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Drug and Vaccine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Pet Drug and Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Drug and Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Drug and Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Pet Drug and Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pet Drug and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Drug and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Drug and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pet Drug and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pet Drug and Vaccine include Boehringer Ingelheim, Ceva, Dechra Veterinary Products, Elanco Animal Health, Meiji, Merck Animal Health, Ouro Fino Saude, Parnell and Vetoquinol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pet Drug and Vaccine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Drug and Vaccine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Drug and Vaccine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pet Drug and Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Drug and Vaccine Segment by Company

Boehringer Ingelheim

Ceva

Dechra Veterinary Products

Elanco Animal Health

Meiji

Merck Animal Health

Ouro Fino Saude

Parnell

Vetoquinol

Virbac

Zoetis

Pet Drug and Vaccine Segment by Type

Drugs

Vaccine

Pet Drug and Vaccine Segment by Application

Dogs

Cats

Other

Pet Drug and Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Drug and Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Drug and Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Drug and Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pet Drug and Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Drug and Vaccine industry.

Chapter 3: Detailed analysis of Pet Drug and Vaccine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Drug and Vaccinerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pet Drug and Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Drugs Table 3. Key Players of Vaccine Table 4. Global Pet Drug and Vaccine Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Dogs Table 6. Key Players of Cats Table 7. Key Players of Other Table 8. Global Pet Drug and Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Pet Drug and Vaccine Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Pet Drug and Vaccine Market Share by Region (2021-2026) Table 11. Global Pet Drug and Vaccine Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Pet Drug and Vaccine Market Share by Region (2027-2032) Table 13. Pet Drug and Vaccine Industry Trends Table 14. Pet Drug and Vaccine Industry Drivers Table 15. Pet Drug and Vaccine Industry Opportunities and Challenges Table 16. Pet Drug and Vaccine Industry Restraints Table 17. Global Pet Drug and Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Pet Drug and Vaccine Revenue Market Share by Company (2021-2026) Table 19. Global Pet Drug and Vaccine Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pet Drug and Vaccine Key Company Head Office and Area Served Table 21. Global Pet Drug and Vaccine Company, Product Type & Application Table 22. Global Pet Drug and Vaccine Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Pet Drug and Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Pet Drug and Vaccine Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pet Drug and Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Pet Drug and Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Pet Drug and Vaccine Revenue Market Share by Type (2021-2026) Table 29. Global Pet Drug and Vaccine Revenue Market Share by Type (2027-2032) Table 30. Global Pet Drug and Vaccine Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pet Drug and Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Pet Drug and Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Pet Drug and Vaccine Revenue Market Share by Application (2021-2026) Table 34. Global Pet Drug and Vaccine Revenue Market Share by Application (2027-2032) Table 35. Boehringer Ingelheim Company Information Table 36. Boehringer Ingelheim Business Overview Table 37. Boehringer Ingelheim Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Boehringer Ingelheim Pet Drug and Vaccine Product Portfolio Table 39. Boehringer Ingelheim Recent Development Table 40. Ceva Company Information Table 41. Ceva Business Overview Table 42. Ceva Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Ceva Pet Drug and Vaccine Product Portfolio Table 44. Ceva Recent Development Table 45. Dechra Veterinary Products Company Information Table 46. Dechra Veterinary Products Business Overview Table 47. Dechra Veterinary Products Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Dechra Veterinary Products Pet Drug and Vaccine Product Portfolio Table 49. Dechra Veterinary Products Recent Development Table 50. Elanco Animal Health Company Information Table 51. Elanco Animal Health Business Overview Table 52. Elanco Animal Health Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Elanco Animal Health Pet Drug and Vaccine Product Portfolio Table 54. Elanco Animal Health Recent Development Table 55. Meiji Company Information Table 56. Meiji Business Overview Table 57. Meiji Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Meiji Pet Drug and Vaccine Product Portfolio Table 59. Meiji Recent Development Table 60. Merck Animal Health Company Information Table 61. Merck Animal Health Business Overview Table 62. Merck Animal Health Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Merck Animal Health Pet Drug and Vaccine Product Portfolio Table 64. Merck Animal Health Recent Development Table 65. Ouro Fino Saude Company Information Table 66. Ouro Fino Saude Business Overview Table 67. Ouro Fino Saude Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Ouro Fino Saude Pet Drug and Vaccine Product Portfolio Table 69. Ouro Fino Saude Recent Development Table 70. Parnell Company Information Table 71. Parnell Business Overview Table 72. Parnell Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Parnell Pet Drug and Vaccine Product Portfolio Table 74. Parnell Recent Development Table 75. Vetoquinol Company Information Table 76. Vetoquinol Business Overview Table 77. Vetoquinol Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Vetoquinol Pet Drug and Vaccine Product Portfolio Table 79. Vetoquinol Recent Development Table 80. Virbac Company Information Table 81. Virbac Business Overview Table 82. Virbac Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Virbac Pet Drug and Vaccine Product Portfolio Table 84. Virbac Recent Development Table 85. Zoetis Company Information Table 86. Zoetis Business Overview Table 87. Zoetis Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Zoetis Pet Drug and Vaccine Product Portfolio Table 89. Zoetis Recent Development Table 90. North America Pet Drug and Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 91. North America Pet Drug and Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 92. North America Pet Drug and Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 93. North America Pet Drug and Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 94. North America Pet Drug and Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Pet Drug and Vaccine Market Size by Country (2021-2026) Table 96. North America Pet Drug and Vaccine Market Size by Country (2027-2032) Table 97. Europe Pet Drug and Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe Pet Drug and Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe Pet Drug and Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe Pet Drug and Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe Pet Drug and Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Pet Drug and Vaccine Market Size by Country (2021-2026) Table 103. Europe Pet Drug and Vaccine Market Size by Country (2027-2032) Table 104. China Pet Drug and Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 105. China Pet Drug and Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 106. China Pet Drug and Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 107. China Pet Drug and Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Pet Drug and Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia Pet Drug and Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia Pet Drug and Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia Pet Drug and Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Pet Drug and Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Pet Drug and Vaccine Market Size by Country (2021-2026) Table 114. Asia Pet Drug and Vaccine Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa Pet Drug and Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa Pet Drug and Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa Pet Drug and Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa Pet Drug and Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa Pet Drug and Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa Pet Drug and Vaccine Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa Pet Drug and Vaccine Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Pet Drug and Vaccine Product Image Figure 2. Global Pet Drug and Vaccine Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pet Drug and Vaccine Market Share by Type: 2025 VS 2032 Figure 4. Drugs Image Figure 5. Vaccine Image Figure 6. Global Pet Drug and Vaccine Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Pet Drug and Vaccine Market Share by Application: 2025 VS 2032 Figure 8. Dogs Image Figure 9. Cats Image Figure 10. Other Image Figure 11. Global Pet Drug and Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 13. Global Pet Drug and Vaccine Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Pet Drug and Vaccine Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Pet Drug and Vaccine Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Pet Drug and Vaccine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pet Drug and Vaccine Revenue Market Share by Type (2021-2032) Figure 20. Global Pet Drug and Vaccine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pet Drug and Vaccine Revenue Market Share by Application (2021-2032) Figure 22. North America Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 23. North America Pet Drug and Vaccine Market Share by Type (2021-2032) Figure 24. North America Pet Drug and Vaccine Market Share by Application (2021-2032) Figure 25. North America Pet Drug and Vaccine Market Share by Country (2021-2032) Figure 26. United States Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 27. Canada Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 29. Europe Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 30. Europe Pet Drug and Vaccine Market Share by Type (2021-2032) Figure 31. Europe Pet Drug and Vaccine Market Share by Application (2021-2032) Figure 32. Europe Pet Drug and Vaccine Market Share by Country (2021-2032) Figure 33. Germany Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 34. France Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 36. Italy Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 37. Russia Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 39. China Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 40. China Pet Drug and Vaccine Market Share by Type (2021-2032) Figure 41. China Pet Drug and Vaccine Market Share by Application (2021-2032) Figure 42. Asia Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 43. Asia Pet Drug and Vaccine Market Share by Type (2021-2032) Figure 44. Asia Pet Drug and Vaccine Market Share by Application (2021-2032) Figure 45. Asia Pet Drug and Vaccine Market Share by Country (2021-2032) Figure 46. Japan Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 50. India Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 51. Australia Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Pet Drug and Vaccine Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Pet Drug and Vaccine Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Pet Drug and Vaccine Market Share by Country (2021-2032) Figure 56. Brazil Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 61. UAE Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 63. Chile Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Drugs
  • Vaccine
Applications
  • Dogs
  • Cats
  • Other
Companies covered
  • Boehringer Ingelheim
  • Ceva
  • Dechra Veterinary Products
  • Elanco Animal Health
  • Meiji
  • Merck Animal Health
  • Ouro Fino Saude
  • Parnell
  • Vetoquinol
  • Virbac
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pet Drug and Vaccine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Drugs
  5. 1.2.3 Vaccine
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Pet Drug and Vaccine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Dogs
  9. 1.3.3 Cats
  10. 1.3.4 Other
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Pet Drug and Vaccine Growth Trends by Region
  13. 1.5.1 Global Pet Drug and Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Pet Drug and Vaccine Market Size by Region (2021-2026)
  15. 1.5.3 Pet Drug and Vaccine Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Pet Drug and Vaccine Market Dynamics
  1. 2.1 Pet Drug and Vaccine Industry Trends
  2. 2.2 Pet Drug and Vaccine Industry Drivers
  3. 2.3 Pet Drug and Vaccine Industry Opportunities and Challenges
  4. 2.4 Pet Drug and Vaccine Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pet Drug and Vaccine Revenue by Company (2021-2026)
  2. 3.2 Global Pet Drug and Vaccine Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pet Drug and Vaccine Key Company Head office and Area Served
  4. 3.4 Global Pet Drug and Vaccine Company, Product Type & Application
  5. 3.5 Global Pet Drug and Vaccine Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pet Drug and Vaccine Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pet Drug and Vaccine Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pet Drug and Vaccine Tier 1, Tier 2, and Tier 3
4 Pet Drug and Vaccine Market by Type
  1. 4.1 Global Pet Drug and Vaccine Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pet Drug and Vaccine Market Size by Type (2021-2032)
  3. 4.3 Global Pet Drug and Vaccine Market Size Share by Type (2021-2032)
5 Pet Drug and Vaccine Market by Application
  1. 5.1 Global Pet Drug and Vaccine Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pet Drug and Vaccine Market Size by Application (2021-2032)
  3. 5.3 Global Pet Drug and Vaccine Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Pet Drug and Vaccine Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Ceva
  8. 6.2.1 Ceva Company Information
  9. 6.2.2 Ceva Business Overview
  10. 6.2.3 Ceva Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Ceva Pet Drug and Vaccine Product Portfolio
  12. 6.2.5 Ceva Recent Developments
  13. 6.3 Dechra Veterinary Products
  14. 6.3.1 Dechra Veterinary Products Company Information
  15. 6.3.2 Dechra Veterinary Products Business Overview
  16. 6.3.3 Dechra Veterinary Products Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Dechra Veterinary Products Pet Drug and Vaccine Product Portfolio
  18. 6.3.5 Dechra Veterinary Products Recent Developments
  19. 6.4 Elanco Animal Health
  20. 6.4.1 Elanco Animal Health Company Information
  21. 6.4.2 Elanco Animal Health Business Overview
  22. 6.4.3 Elanco Animal Health Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Elanco Animal Health Pet Drug and Vaccine Product Portfolio
  24. 6.4.5 Elanco Animal Health Recent Developments
  25. 6.5 Meiji
  26. 6.5.1 Meiji Company Information
  27. 6.5.2 Meiji Business Overview
  28. 6.5.3 Meiji Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Meiji Pet Drug and Vaccine Product Portfolio
  30. 6.5.5 Meiji Recent Developments
  31. 6.6 Merck Animal Health
  32. 6.6.1 Merck Animal Health Company Information
  33. 6.6.2 Merck Animal Health Business Overview
  34. 6.6.3 Merck Animal Health Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Merck Animal Health Pet Drug and Vaccine Product Portfolio
  36. 6.6.5 Merck Animal Health Recent Developments
  37. 6.7 Ouro Fino Saude
  38. 6.7.1 Ouro Fino Saude Company Information
  39. 6.7.2 Ouro Fino Saude Business Overview
  40. 6.7.3 Ouro Fino Saude Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Ouro Fino Saude Pet Drug and Vaccine Product Portfolio
  42. 6.7.5 Ouro Fino Saude Recent Developments
  43. 6.8 Parnell
  44. 6.8.1 Parnell Company Information
  45. 6.8.2 Parnell Business Overview
  46. 6.8.3 Parnell Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Parnell Pet Drug and Vaccine Product Portfolio
  48. 6.8.5 Parnell Recent Developments
  49. 6.9 Vetoquinol
  50. 6.9.1 Vetoquinol Company Information
  51. 6.9.2 Vetoquinol Business Overview
  52. 6.9.3 Vetoquinol Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Vetoquinol Pet Drug and Vaccine Product Portfolio
  54. 6.9.5 Vetoquinol Recent Developments
  55. 6.10 Virbac
  56. 6.10.1 Virbac Company Information
  57. 6.10.2 Virbac Business Overview
  58. 6.10.3 Virbac Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Virbac Pet Drug and Vaccine Product Portfolio
  60. 6.10.5 Virbac Recent Developments
  61. 6.11 Zoetis
  62. 6.11.1 Zoetis Company Information
  63. 6.11.2 Zoetis Business Overview
  64. 6.11.3 Zoetis Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Zoetis Pet Drug and Vaccine Product Portfolio
  66. 6.11.5 Zoetis Recent Developments
7 North America
  1. 7.1 North America Pet Drug and Vaccine Market Size (2021-2032)
  2. 7.2 North America Pet Drug and Vaccine Market Size by Type
  3. 7.2.1 North America Pet Drug and Vaccine Market Size by Type (2021-2026)
  4. 7.2.2 North America Pet Drug and Vaccine Market Size by Type (2027-2032)
  5. 7.2.3 North America Pet Drug and Vaccine Market Share by Type (2021-2032)
  6. 7.3 North America Pet Drug and Vaccine Market Size by Application
  7. 7.3.1 North America Pet Drug and Vaccine Market Size by Application (2021-2026)
  8. 7.3.2 North America Pet Drug and Vaccine Market Size by Application (2027-2032)
  9. 7.3.3 North America Pet Drug and Vaccine Market Share by Application (2021-2032)
  10. 7.4 North America Pet Drug and Vaccine Market Size by Country
  11. 7.4.1 North America Pet Drug and Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pet Drug and Vaccine Market Size by Country (2021-2026)
  13. 7.4.3 North America Pet Drug and Vaccine Market Size by Country (2027-2032)
  14. 7.4.4 North America Pet Drug and Vaccine Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pet Drug and Vaccine Market Size (2021-2032)
  2. 8.2 Europe Pet Drug and Vaccine Market Size by Type
  3. 8.2.1 Europe Pet Drug and Vaccine Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pet Drug and Vaccine Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pet Drug and Vaccine Market Share by Type (2021-2032)
  6. 8.3 Europe Pet Drug and Vaccine Market Size by Application
  7. 8.3.1 Europe Pet Drug and Vaccine Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pet Drug and Vaccine Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pet Drug and Vaccine Market Share by Application (2021-2032)
  10. 8.4 Europe Pet Drug and Vaccine Market Size by Country
  11. 8.4.1 Europe Pet Drug and Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pet Drug and Vaccine Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pet Drug and Vaccine Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pet Drug and Vaccine Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pet Drug and Vaccine Market Size (2021-2032)
  2. 9.2 China Pet Drug and Vaccine Market Size by Type
  3. 9.2.1 China Pet Drug and Vaccine Market Size by Type (2021-2026)
  4. 9.2.2 China Pet Drug and Vaccine Market Size by Type (2027-2032)
  5. 9.2.3 China Pet Drug and Vaccine Market Share by Type (2021-2032)
  6. 9.3 China Pet Drug and Vaccine Market Size by Application
  7. 9.3.1 China Pet Drug and Vaccine Market Size by Application (2021-2026)
  8. 9.3.2 China Pet Drug and Vaccine Market Size by Application (2027-2032)
  9. 9.3.3 China Pet Drug and Vaccine Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pet Drug and Vaccine Market Size (2021-2032)
  2. 10.2 Asia Pet Drug and Vaccine Market Size by Type
  3. 10.2.1 Asia Pet Drug and Vaccine Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pet Drug and Vaccine Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pet Drug and Vaccine Market Share by Type (2021-2032)
  6. 10.3 Asia Pet Drug and Vaccine Market Size by Application
  7. 10.3.1 Asia Pet Drug and Vaccine Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pet Drug and Vaccine Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pet Drug and Vaccine Market Share by Application (2021-2032)
  10. 10.4 Asia Pet Drug and Vaccine Market Size by Country
  11. 10.4.1 Asia Pet Drug and Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pet Drug and Vaccine Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pet Drug and Vaccine Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pet Drug and Vaccine Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pet Drug and Vaccine Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pet Drug and Vaccine Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pet Drug and Vaccine Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pet Drug and Vaccine Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pet Drug and Vaccine Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pet Drug and Vaccine Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pet Drug and Vaccine Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pet Drug and Vaccine Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pet Drug and Vaccine Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pet Drug and Vaccine Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pet Drug and Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pet Drug and Vaccine Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pet Drug and Vaccine Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pet Drug and Vaccine Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst